Racial Variation in CAG Repeat Lengths Within the Androgen Receptor Gene Among Prostate Cancer Patients of Lower Socioeconomic Status
Authors:
- Charles L. BennettCBCharles L. Bennett
- Douglas K. PriceDPDouglas K. Price
- Simon KimSKSimon Kim
- Dachao LiuDLDachao Liu
- Borko D. JovanovicBJBorko D. Jovanovic
- Derek NathanDNDerek Nathan
- Margaret E. JohnsonMJMargaret E. Johnson
- Jeffrey S. MontgomeryJMJeffrey S. Montgomery
- Kelly CudeKCKelly Cude
- Justin C. BrockbankJBJustin C. Brockbank
- Oliver SartorOSOliver Sartor
- William D. FiggWFWilliam D. Figg
- 1 September 2002
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (17) , 3599-3604
Abstract
PURPOSE: To evaluate (1) whether there were racial differences in the androgen receptor gene CAG repeat length and in clinical or laboratory attributes of prostate cancer at the time of diagnosis; (2) whether there were differences in race, Gleason score, prostate-specific antigen (PSA) level, and stage at diagnosis by androgen receptor gene CAG repeat length; and (3) whether sociodemographic, clinical, and laboratory based factors might be associated with advanced-stage prostate cancer. To our knowledge, our study is the first to report on CAG repeat lengths in a cohort of prostate cancer patients, which includes large numbers of African-American men. METHODS: CAG repeat lengths on the androgen receptor gene were evaluated for 151 African-American and 168 white veterans with prostate cancer. The χ2 test, t test, and logistic regression analyses were used to evaluate the associations between CAG repeat lengths and race, stage, histologic grade, and PSA levels at diagnosis. RESULTS: The mean age of the cohort at the time of diagnosis was 68.7 years. At presentation, 42.0% had stage D prostate cancer, 26.5% had Gleason scores of 8 to 10, and 53.0% had PSA levels ≥ 10 ng/dL. Mean androgen receptor gene CAG repeat length for white veterans was 21.9 (SD, 3.5) versus 19.8 (SD, 3.2) for African-American veterans (P = .001). Men with shorter CAG repeats were more likely to have stage D prostate cancer (P = .09) but were not more likely to have a higher PSA concentration or Gleason score. CONCLUSION: In this cohort of men with prostate cancer, short CAG repeat length on the androgen receptor gene was associated with African-American race and possibly with higher stage but not with other clinical or pathologic findings.Keywords
This publication has 18 references indexed in Scilit:
- Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer riskHuman Genetics, 2001
- Tandem CAG Repeats of the Androgen Receptor Gene and Prostate Cancer Risk in Black and White MenEndocrine, 2001
- Racial Variation in Prostate Cancer Incidence and in Hormonal System Markers Among Male Health ProfessionalsJNCI: Journal of the National Cancer Institute, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer riskBritish Journal of Cancer, 1999
- Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancerUrology, 1999
- The CAG repeat within the androgen receptor gene and its relationship to prostate cancerProceedings of the National Academy of Sciences, 1997
- Determination of cag repeat length in the androgen-receptor gene using frozen serumUrology, 1997
- Association of Prostate Cancer Risk With Genetic Polymorphisms in Vitamin D Receptor and Androgen ReceptorJNCI: Journal of the National Cancer Institute, 1997
- Re: Prostate Cancer and the Androgen ReceptorJNCI: Journal of the National Cancer Institute, 1994